Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT04895358
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for he Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Locally Recurrent Inoperable or Metastatic Breast Cancer (KEYNOTE-B49)
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Zuberi, Lara
Practice
Breast
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04895358
Secondary Trial ID Number
MK-3475-B49-0013
Keywords
Treatment